Fenfluramine Shows Long-Term Benefits for Lennox-Gastaut Patients
This study looked at the long-term effects of a medication called fenfluramine on people with Lennox-Gastaut syndrome (LGS), a type of epilepsy.
-
-
Drug-Resistant Epilepsy | Epilepsy Research Summaries | Genetics | Pediatrics | Recent Research | Safety & First Aid
High Success Rates for Early Surgery in Childhood Epilepsy
This study focused on children with a specific type of epilepsy called focal cortical dysplasia (FCD), which often does not respond to medication.
-
SEEG and SDE Offer Safe Options for Seizure Localization
Researchers studied two methods used to monitor brain activity in people with epilepsy: stereoelectroencephalography (SEEG) and subdural electrodes (SDE).
-
Managing Epilepsy in Women During Reproductive Years
This study focused on women with epilepsy who are of childbearing age, a group that faces specific challenges related to their condition and reproductive health.
-
Midazolam Use for Epilepsy: UK vs Norway Insights
This study looked at how epilepsy professionals in the UK and Norway use a rescue medication called midazolam to treat prolonged seizures, known as status epilepticus.
-
Epilepsy Research Summaries | Genetics | Imaging & EEG | Pediatrics | Recent Research | Safety & First Aid
Flashing Pens Can Trigger Seizures in Some Children
Researchers studied two young girls, ages 9 and 10, who experienced seizures triggered by a red-light flashing pen that is popular among children.
-
Managing Risks in Clinical Trials for Digital Health Tools
Researchers studied how to manage risks in clinical trials for a digital tool designed to help doctors make treatment decisions for epilepsy.
-
Brivaracetam May Be Safer Than Levetiracetam for Seizures
A study was conducted to compare two medications used to treat seizures: levetiracetam (LEV) and brivaracetam (BRV).
-
Reviewing Safety of Anticoagulants with Seizure Medications
This study focuses on the safety and effectiveness of using direct oral anticoagulants (DOACs) alongside antiseizure medications (ASMs) in patients aged 8 years and older.
